| Endometrial Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 104show all (up to 200) |
|---|
| → investigated in trials for | Paclitaxelsmall_molecule 42 trials (15 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 31 trials (7 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 29 trials (10 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 20 trials (15 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endometrial Carcinoma | 4 | Observed | clinicaltrials | graph → |